Antifolate pseudo-resistance due to elevated levels of thymidine and hypoxanthine in a commercial serum preparation.

Marcel Simon, Johannes Blatter, Christof Granzow

Journal: Anticancer research 2007;27(2):769-73

PMID: 17465201

Free Full Text on HighWire View on PubMed

Abstract

BACKGROUND

Batch variability of sera used for cell culture is of considerable experimental concern. A novel fetal calf serum product, FCS Gold, was claimed to be the first defined fetal calf serum free of batch variation.

MATERIALS AND METHODS

The efficacy of methotrexate (MTX) and LY231514 (multitargeted antifolate, MTA) in CCRF-CEM cells and KB cells was compared using media supplemented with FCS Gold or conventional fetal bovine serum.

RESULTS

IC50 values from tests using conventional serum corresponded to published data. FCS Gold fully protected the cells from antifolate drug cytotoxicity. Dialysis of FCS Gold restored responsiveness to antifolate drugs. Elevated levels of hypoxanthine and thymidine were present in FCS Gold. They were approximately 10-fold greater than the concentrations required to overcome growth arrest mediated by 2 microM MTX.

CONCLUSION

FCS Gold or identical products, e.g. FBS Gold, should not be used in studies on antifolate drug action.

Address: Department Molekulare Toxikologie (G120), Deutsches Krebsforschungszentrum, D-69120 Heidelberg, Germany.

Link outs

Free resources

Full Text Sources:

http://ar.iiarjournals.org/lookup/pmidlookup?view=...

MeSH Terms: Cell Culture Techniques, Cell Growth Processes, Cell Line, Tumor, Culture Media, Dialysis, Drug Screening Assays, Antitumor, Folic Acid Antagonists, Glutamates, Guanine, Humans, Hypoxanthine, KB Cells, Leukemia, T-Cell, Methotrexate, Pemetrexed, Serum, Thymidine